Breckenridge Pharmaceutical Inc, the US subsidiary of Towa International that markets, distributes, and sells generic medicines in the United States, on Wednesday announced a new partnership with India-based Maiva Pharma Pvt Ltd focused on sterile injectable products to be supplied primarily to hospitals and clinics.

Under the agreement, Maiva will serve as a key manufacturing partner for several injectable products.

"This collaboration strengthens our growing presence in the hospital channel and reinforces our commitment to expanding patient access to high-quality, affordable medicines," said Brian Guy, president and chief commercial officer of Breckenridge. "It also represents a significant milestone in Breckenridge's evolution into three clearly defined patient-focused business lines, specialty, hospital, and retail, allowing us to better serve patients while providing healthcare providers with reliable and cost-effective treatment options."